Rhythm Pharmaceuticals, Inc. RYTM
93.44 USD +0.87 +0.94%
At close · Nov 2
93.44 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
74.50 52-week range 122.20
- YTD
- -12.71%
- 1 year
- -17.86%
- Open
- 93.13
- Prev close
- 92.57
- Mkt cap
- 6.43B
- Vol
- 2.00M
- Avg vol
- 658.96K
- EPS
- -3.16
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 93.04
- High
- 95.06
- Forward P/E
- -148.67
- Beta
- 2.13
- Short ratio
- 13.64
- Inst. own
- 115.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 97.18
- 200-d avg
- 97.09
- 1y target
- 140.53
5D chart
Chart tools
Chart is warming up
The five-day price history for RYTM has not been loaded yet. Try again in a moment.
Altman Z-Score
12.86 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
P/E -34.4×
P/S 36.7×
P/B 25.8×
P/FCF -59.6×
EV/EBITDA -39.7×
EV/Sales 36.4×
FCF Yield -1.7%
Gross Margin 89.7%
Operating Margin -101.2%
Net Margin -103.6%
ROE -72.8%
ROIC -51.2%
ROA -40.9%
Revenue 45.8%
Operating Income 27.7%
EPS (diluted) 28.3%
Free Cash Flow -2.4%
Current Ratio 4.4×
Quick Ratio 4.2×
Debt / Equity 0.0×
Net Debt / EBITDA 0.3×
Interest Coverage -9.3×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31